Logo image of CGNX

COGNEX CORP (CGNX) Stock Fundamental Analysis

NASDAQ:CGNX - Nasdaq - US1924221039 - Common Stock

39.73  +0.37 (+0.94%)

After market: 39.86 +0.13 (+0.33%)

Fundamental Rating

6

CGNX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 126 industry peers in the Electronic Equipment, Instruments & Components industry. CGNX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, CGNX is valued expensive at the moment. With these ratings, CGNX could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CGNX had positive earnings in the past year.
In the past year CGNX had a positive cash flow from operations.
CGNX had positive earnings in each of the past 5 years.
Each year in the past 5 years CGNX had a positive operating cash flow.
CGNX Yearly Net Income VS EBIT VS OCF VS FCFCGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.32%, CGNX is in the better half of the industry, outperforming 68.59% of the companies in the same industry.
The Return On Equity of CGNX (5.68%) is better than 61.98% of its industry peers.
CGNX has a Return On Invested Capital (4.22%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for CGNX is above the industry average of 9.03%.
The last Return On Invested Capital (4.22%) for CGNX is well below the 3 year average (11.06%), which needs to be investigated, but indicates that CGNX had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.32%
ROE 5.68%
ROIC 4.22%
ROA(3y)10.2%
ROA(5y)10.24%
ROE(3y)14.03%
ROE(5y)14.22%
ROIC(3y)11.06%
ROIC(5y)10.1%
CGNX Yearly ROA, ROE, ROICCGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

The Profit Margin of CGNX (10.10%) is better than 81.82% of its industry peers.
In the last couple of years the Profit Margin of CGNX has declined.
The Operating Margin of CGNX (10.69%) is better than 80.99% of its industry peers.
CGNX's Operating Margin has declined in the last couple of years.
CGNX's Gross Margin of 68.40% is amongst the best of the industry. CGNX outperforms 98.35% of its industry peers.
In the last couple of years the Gross Margin of CGNX has remained more or less at the same level.
Industry RankSector Rank
OM 10.69%
PM (TTM) 10.1%
GM 68.4%
OM growth 3Y-16.76%
OM growth 5Y-11.78%
PM growth 3Y-14.63%
PM growth 5Y-13.05%
GM growth 3Y-1.25%
GM growth 5Y-0.73%
CGNX Yearly Profit, Operating, Gross MarginsCGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

9

2. Health

2.1 Basic Checks

CGNX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CGNX has less shares outstanding
The number of shares outstanding for CGNX has been increased compared to 5 years ago.
CGNX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CGNX Yearly Shares OutstandingCGNX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
CGNX Yearly Total Debt VS Total AssetsCGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 9.39 indicates that CGNX is not in any danger for bankruptcy at the moment.
CGNX has a Altman-Z score of 9.39. This is amongst the best in the industry. CGNX outperforms 86.78% of its industry peers.
There is no outstanding debt for CGNX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.39
ROIC/WACC0.41
WACC10.32%
CGNX Yearly LT Debt VS Equity VS FCFCGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 3.94 indicates that CGNX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.94, CGNX is in the better half of the industry, outperforming 68.59% of the companies in the same industry.
CGNX has a Quick Ratio of 3.03. This indicates that CGNX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.03, CGNX is in the better half of the industry, outperforming 76.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.94
Quick Ratio 3.03
CGNX Yearly Current Assets VS Current LiabilitesCGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

5

3. Growth

3.1 Past

CGNX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.14%.
The earnings per share for CGNX have been decreasing by -10.30% on average. This is quite bad
Looking at the last year, CGNX shows a small growth in Revenue. The Revenue has grown by 0.15% in the last year.
CGNX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.76% yearly.
EPS 1Y (TTM)-26.14%
EPS 3Y-11.82%
EPS 5Y-10.3%
EPS Q2Q%25%
Revenue 1Y (TTM)0.15%
Revenue growth 3Y1.08%
Revenue growth 5Y0.76%
Sales Q2Q%19.01%

3.2 Future

CGNX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.57% yearly.
The Revenue is expected to grow by 10.67% on average over the next years. This is quite good.
EPS Next Y-2.42%
EPS Next 2Y16.47%
EPS Next 3Y23.05%
EPS Next 5Y24.57%
Revenue Next Year9.15%
Revenue Next 2Y10.21%
Revenue Next 3Y11.43%
Revenue Next 5Y10.67%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CGNX Yearly Revenue VS EstimatesCGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CGNX Yearly EPS VS EstimatesCGNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 61.12, CGNX can be considered very expensive at the moment.
CGNX's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.96, CGNX is valued quite expensively.
Based on the Price/Forward Earnings ratio of 40.68, the valuation of CGNX can be described as expensive.
CGNX's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 24.11. CGNX is valued rather expensively when compared to this.
Industry RankSector Rank
PE 61.12
Fwd PE 40.68
CGNX Price Earnings VS Forward Price EarningsCGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

CGNX's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CGNX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 73.87
EV/EBITDA 50.44
CGNX Per share dataCGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The decent profitability rating of CGNX may justify a higher PE ratio.
A more expensive valuation may be justified as CGNX's earnings are expected to grow with 23.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.47%
EPS Next 3Y23.05%

5

5. Dividend

5.1 Amount

CGNX has a yearly dividend return of 0.85%, which is pretty low.
CGNX's Dividend Yield is rather good when compared to the industry average which is at 1.89. CGNX pays more dividend than 86.78% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, CGNX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.85%

5.2 History

The dividend of CGNX is nicely growing with an annual growth rate of 9.01%!
CGNX has been paying a dividend for at least 10 years, so it has a reliable track record.
CGNX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.01%
Div Incr Years3
Div Non Decr Years3
CGNX Yearly Dividends per shareCGNX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2

5.3 Sustainability

CGNX pays out 57.83% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of CGNX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP57.83%
EPS Next 2Y16.47%
EPS Next 3Y23.05%
CGNX Yearly Income VS Free CF VS DividendCGNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
CGNX Dividend Payout.CGNX Dividend Payout, showing the Payout Ratio.CGNX Dividend Payout.PayoutRetained Earnings

COGNEX CORP

NASDAQ:CGNX (1/17/2025, 8:00:00 PM)

After market: 39.86 +0.13 (+0.33%)

39.73

+0.37 (+0.94%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)02-13 2025-02-13/amc
Inst Owners99.53%
Inst Owner Change-0.04%
Ins Owners0.23%
Ins Owner Change0.1%
Market Cap6.81B
Analysts75
Price Target47.76 (20.21%)
Short Float %2.12%
Short Ratio3.18
Dividend
Industry RankSector Rank
Dividend Yield 0.85%
Yearly Dividend0.29
Dividend Growth(5Y)9.01%
DP57.83%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.9%
Min EPS beat(2)3.88%
Max EPS beat(2)9.93%
EPS beat(4)4
Avg EPS beat(4)16.92%
Min EPS beat(4)3.88%
Max EPS beat(4)41.77%
EPS beat(8)7
Avg EPS beat(8)14.96%
EPS beat(12)10
Avg EPS beat(12)17.01%
EPS beat(16)12
Avg EPS beat(16)12.67%
Revenue beat(2)0
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-2.41%
Max Revenue beat(2)-1.24%
Revenue beat(4)2
Avg Revenue beat(4)0.43%
Min Revenue beat(4)-2.41%
Max Revenue beat(4)3.11%
Revenue beat(8)4
Avg Revenue beat(8)0.06%
Revenue beat(12)7
Avg Revenue beat(12)0.9%
Revenue beat(16)9
Avg Revenue beat(16)0.9%
PT rev (1m)-0.13%
PT rev (3m)-1.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-32.72%
EPS NY rev (1m)0.1%
EPS NY rev (3m)0.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.61%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-0.31%
Valuation
Industry RankSector Rank
PE 61.12
Fwd PE 40.68
P/S 7.73
P/FCF 73.87
P/OCF 60.74
P/B 4.35
P/tB 6.35
EV/EBITDA 50.44
EPS(TTM)0.65
EY1.64%
EPS(NY)0.98
Fwd EY2.46%
FCF(TTM)0.54
FCFY1.35%
OCF(TTM)0.65
OCFY1.65%
SpS5.14
BVpS9.14
TBVpS6.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.32%
ROE 5.68%
ROCE 4.98%
ROIC 4.22%
ROICexc 4.98%
ROICexgc 7.2%
OM 10.69%
PM (TTM) 10.1%
GM 68.4%
FCFM 10.46%
ROA(3y)10.2%
ROA(5y)10.24%
ROE(3y)14.03%
ROE(5y)14.22%
ROIC(3y)11.06%
ROIC(5y)10.1%
ROICexc(3y)13.78%
ROICexc(5y)12.75%
ROICexgc(3y)17.38%
ROICexgc(5y)16.06%
ROCE(3y)13.04%
ROCE(5y)11.91%
ROICexcg growth 3Y-15.63%
ROICexcg growth 5Y-21.86%
ROICexc growth 3Y-20.46%
ROICexc growth 5Y-24.84%
OM growth 3Y-16.76%
OM growth 5Y-11.78%
PM growth 3Y-14.63%
PM growth 5Y-13.05%
GM growth 3Y-1.25%
GM growth 5Y-0.73%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 62.9%
Cap/Sales 2.26%
Interest Coverage 250
Cash Conversion 89.1%
Profit Quality 103.58%
Current Ratio 3.94
Quick Ratio 3.03
Altman-Z 9.39
F-Score5
WACC10.32%
ROIC/WACC0.41
Cap/Depr(3y)94.11%
Cap/Depr(5y)83.93%
Cap/Sales(3y)2.07%
Cap/Sales(5y)2.17%
Profit Quality(3y)96.61%
Profit Quality(5y)106.69%
High Growth Momentum
Growth
EPS 1Y (TTM)-26.14%
EPS 3Y-11.82%
EPS 5Y-10.3%
EPS Q2Q%25%
EPS Next Y-2.42%
EPS Next 2Y16.47%
EPS Next 3Y23.05%
EPS Next 5Y24.57%
Revenue 1Y (TTM)0.15%
Revenue growth 3Y1.08%
Revenue growth 5Y0.76%
Sales Q2Q%19.01%
Revenue Next Year9.15%
Revenue Next 2Y10.21%
Revenue Next 3Y11.43%
Revenue Next 5Y10.67%
EBIT growth 1Y-44.29%
EBIT growth 3Y-15.86%
EBIT growth 5Y-11.11%
EBIT Next Year19.67%
EBIT Next 3Y31.35%
EBIT Next 5Y26.75%
FCF growth 1Y-56.47%
FCF growth 3Y-26.81%
FCF growth 5Y-13.58%
OCF growth 1Y-51.7%
OCF growth 3Y-22.48%
OCF growth 5Y-12.76%